Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Conformis Inc CS (CFMS)

Conformis Inc CS (CFMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 25,256
  • Shares Outstanding, K 7,517
  • Annual Sales, $ 99,860 K
  • Annual Income, $ -2,410 K
  • 60-Month Beta 1.10
  • Price/Sales 0.28
  • Price/Cash Flow 15.13
  • Price/Book 0.46
Trade CFMS with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -1.84
  • Number of Estimates 1
  • High Estimate -1.84
  • Low Estimate -1.84
  • Prior Year -2.25
  • Growth Rate Est. (year over year) +18.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.20 +185.42%
on 11/16/22
3.85 -11.04%
on 12/01/22
+0.79 (+29.98%)
since 11/04/22
3-Month
1.20 +185.42%
on 11/16/22
7.25 -52.76%
on 09/14/22
-3.08 (-47.31%)
since 09/02/22
52-Week
1.20 +185.42%
on 11/16/22
22.88 -85.03%
on 12/08/21
-15.58 (-81.98%)
since 12/03/21

Most Recent Stories

More News
ConforMIS (CFMS) Reports Q3 Loss, Misses Revenue Estimates

ConforMIS (CFMS) delivered earnings and revenue surprises of -14.29% and 0.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CFMS : 3.47 (+3.27%)
MASI : 142.17 (-2.29%)
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates

ConforMIS (CFMS) delivered earnings and revenue surprises of -12.50% and 1.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CFMS : 3.47 (+3.27%)
RPID : 1.8400 (-1.63%)
Conformis Reports Second Quarter 2022 Financial Results

BILLERICA, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee...

CFMS : 3.47 (+3.27%)
Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants

Agreement enables interested Vizient members, including academic medical centers, acute care facilities, and ambulatory surgery centers (ASCs), to purchase...

CFMS : 3.47 (+3.27%)
Conformis, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

BILLERICA, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and...

CFMS : 3.47 (+3.27%)
Conformis, Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022

BILLERICA, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and...

CFMS : 3.47 (+3.27%)
Conformis, Inc. to Participate in the H.C. Wainwright Global Investment Conference

BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and...

CFMS : 3.47 (+3.27%)
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates

ConforMIS (CFMS) delivered earnings and revenue surprises of -28.57% and 11.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CFMS : 3.47 (+3.27%)
HTGM : 0.2901 (-9.34%)
Conformis Reports First Quarter 2022 Financial Results

BILLERICA, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee...

CFMS : 3.47 (+3.27%)
SeaSpine Holdings (SPNE) Reports Q1 Loss, Tops Revenue Estimates

SeaSpine (SPNE) delivered earnings and revenue surprises of -28.57% and 3.54%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

SPNE : 7.62 (-2.81%)
CFMS : 3.47 (+3.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The Company's iFit technology platform consists of iFit Design, iFit Printing and iFit Just-in-Time Delivery. It operates primarily in the United States, Germany and the United Kingdom. The...

See More

Key Turning Points

3rd Resistance Point 4.21
2nd Resistance Point 3.94
1st Resistance Point 3.65
Last Price 3.47
1st Support Level 3.09
2nd Support Level 2.82
3rd Support Level 2.53

See More

52-Week High 22.88
Fibonacci 61.8% 14.60
Fibonacci 50% 12.04
Fibonacci 38.2% 9.48
Last Price 3.47
52-Week Low 1.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar